ASCO: Taking Abiraterone Acetate With Low-Fat Meal Can Cut Cost

Share this content:
ASCO: Taking Abiraterone Acetate With Low-Fat Meal Can Cut Cost
ASCO: Taking Abiraterone Acetate With Low-Fat Meal Can Cut Cost

MONDAY, Feb. 20, 2017 (HealthDay News) -- Eating a low-fat meal when taking an expensive prostate cancer drug can cut the cost of the medication by three-quarters, according to research presented at the American Society of Clinical Oncology's annual Genitourinary Cancers Symposium, held from Feb. 16 to 18 in Orlando, Fla.

Zytiga (abiraterone acetate) costs more than $9,000 a month and patients typically remain on the drug for 12 to 18 months, researchers said. Even patients with the best health insurance can have copays of $1,000 to $3,000 a month.

The authors of this study found similar outcomes between 36 advanced prostate cancer patients who took 250 mg of the drug with a low-fat breakfast and 36 patients who took the standard dose of 1,000 mg on an empty stomach. For both groups, the time to disease progression was about 14 months. The researchers noted that taking the drug with a high-fat meal increased absorption of the drug even more. But high-fat meals raised levels of the drug more unpredictably than low-fat meals did, they said.

"Our results warrant consideration by doctors who care for prostate cancer patients, as well as payers," study author Russell Szmulewitz, M.D., an assistant professor of medicine at the University of Chicago, said in a university news release.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Higher Risk of Adverse Outcomes for Births to Young CA Survivors

Higher Risk of Adverse Outcomes for Births to ...

Increased risks among live births for adolescent and young adult cancer survivors

Many Youths With Diabetes Not Receiving Eye Examinations

Many Youths With Diabetes Not Receiving Eye Examinations

Racial minorities less likely to undergo eye exam; increasing net worth increases likelihood of eye exam

Mortality Risk Impacts Colon CA Screening in Dialysis Patients

Mortality Risk Impacts Colon CA Screening in Dialysis ...

Higher rate of screening among patients most likely to receive a transplant

is free, fast, and customized just for you!

Already a member?

Sign In Now »